Two Photon Microscopy for Skin Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to evaluate how effectively a new imaging method, called two-photon microscopy imaging, detects residual basal cell carcinoma (a common type of skin cancer) during Mohs surgery. The researchers seek to determine if this imaging technique matches the current method, frozen section histology, in verifying complete cancer removal. Candidates for this trial include those undergoing Mohs surgery for basal cell carcinoma at the study site who can read and understand the consent form. As an unphased trial, this study provides a unique opportunity to contribute to the advancement of imaging techniques in skin cancer surgery.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that two photon microscopy imaging is safe for detecting residual basal cell carcinoma?
Research has shown that using two-photon fluorescence microscopy on human skin is safe. In one study, over 70% of skin cells remained healthy even at the microscope's highest power, indicating that the cells stayed healthy and the microscope did not irritate the skin.
Additionally, other skin studies have used two-photon microscopy without reporting any serious side effects, suggesting it is generally well-tolerated. However, as with any medical procedure, individual differences should be considered, and consultation with healthcare providers is important.12345Why are researchers excited about this trial?
Researchers are excited about two photon microscopy (TPFM) for skin cancer because it offers a non-invasive way to evaluate surgical margins during skin cancer removal. Unlike traditional methods that rely on physical tissue removal and histopathological examination, TPFM imaging allows doctors to visualize the cellular structure of the skin in real-time, potentially reducing the need for additional surgeries. This technique could lead to quicker, more accurate assessments, helping to ensure all cancerous cells are removed while preserving as much healthy tissue as possible.
What evidence suggests that two photon microscopy is effective for detecting skin cancer?
Research has shown that two-photon fluorescence microscopy (TPFM), a special imaging method, can help detect nonmelanoma skin cancers, such as basal cell carcinoma, during surgery. In this trial, participants will undergo TPFM imaging of surgical margins. Studies have found that TPFM provides real-time images, enabling doctors to see cancer cells as they operate, which helps ensure the removal of all cancerous tissue. Previous research suggests TPFM effectively spots cancer cells in skin samples. This imaging technique could revolutionize fast and accurate diagnosis during skin cancer surgeries.12678
Who Is on the Research Team?
Michael G Giacomelli, Ph.D
Principal Investigator
University of Rochester
Are You a Good Fit for This Trial?
This trial is for individuals who can read and understand a consent form and are currently undergoing Mohs surgery for basal cell carcinoma (BCC) at the location where the study is being conducted.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Mohs surgery with TPFM imaging of surgical margins followed by standard of care frozen section analysis
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Two photon microscopy imaging
Two photon microscopy imaging is already approved in United States, European Union for the following indications:
- Diagnostic tool for non-melanoma skin cancers, including basal cell carcinoma and squamous cell carcinoma
- Research and diagnostic tool for skin cancers, including basal cell carcinoma
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Rochester
Lead Sponsor
Rochester Dermatologic Surgery
Collaborator